Myasthenia gravis (MG) is classified into five stages based on which muscles are affected and how severe the weakness is. The staging system used by neurologists worldwide comes from the Myasthenia Gravis Foundation of America (MGFA), which groups patients into Classes I through V. Symptoms often reach their worst point within one to two years of the disease starting, and the classification captures where a person falls on that spectrum at any given time.
How the MGFA Classification Works
Unlike cancer staging, where you move through stages in a predictable order, MG classification describes your current level of severity. You can move between classes as your disease worsens, improves with treatment, or fluctuates over time. The system also splits Classes II through IV into “a” and “b” subtypes based on which muscle groups are most affected: “a” means the arms, legs, and trunk muscles are predominantly involved, while “b” means the throat, swallowing, and breathing muscles bear the brunt of it. The “b” subtypes generally carry more immediate risk because they can affect your ability to eat and breathe.
Class I: Ocular Myasthenia
Class I involves only the eye muscles. You might notice a drooping eyelid (on one or both sides), double vision, or difficulty keeping your eyes open, especially later in the day. All other muscle groups remain normal. Many people start here, and for some, the disease never spreads beyond the eyes.
However, a significant number of people with ocular MG do eventually develop weakness elsewhere. One retrospective study found that about 39% of patients who started with eye-only symptoms progressed to generalized disease over several years, with a median conversion time of 16 months. The likelihood of progression was roughly 26% at two years and 34% at four years. The first two years after symptom onset are the highest-risk window for this shift.
Class II: Mild Generalized Weakness
Class II means weakness has spread beyond the eyes, but it’s still mild. Eye symptoms of any severity can also be present. The two subtypes distinguish where the weakness shows up most:
- Class IIa: Weakness predominantly affects the limbs and trunk. You might have trouble lifting your arms overhead, climbing stairs, or holding your head up, with only minor difficulty swallowing or speaking.
- Class IIb: Weakness predominantly affects the throat and breathing muscles. Slurred speech, difficulty chewing, or a nasal-sounding voice may be more noticeable than limb weakness.
At this stage, daily activities are still manageable for most people, though fatigue and muscle weakness become more apparent with sustained effort.
Class III: Moderate Generalized Weakness
Class III involves moderate weakness in muscles beyond the eyes. The functional impact is more noticeable here. Tasks that were merely tiring in Class II may now be genuinely difficult.
- Class IIIa: Limb and trunk muscles are predominantly affected. Walking longer distances, carrying groceries, or getting up from a chair may become challenging.
- Class IIIb: Throat and breathing muscles are predominantly affected. Swallowing may require more effort, and breathing can feel labored during physical activity. Limb and trunk weakness can be present to a lesser or equal degree.
Class IV: Severe Generalized Weakness
Class IV represents severe weakness that significantly limits daily function. Eye muscle weakness of any severity can accompany it.
- Class IVa: Severe weakness concentrated in the limbs and trunk. Independent mobility is significantly impaired.
- Class IVb: Severe weakness concentrated in the throat and breathing muscles. This subtype includes people who need a feeding tube because they can no longer swallow safely, even if they don’t yet require help breathing through a machine.
People in Class IV typically need substantial help with everyday activities and are at higher risk of progressing to a myasthenic crisis.
Class V: Myasthenic Crisis
Class V is the most serious stage. It means a person needs a breathing tube, with or without mechanical ventilation, because the muscles that control breathing have weakened to a dangerous degree. This is a medical emergency.
Roughly 15% to 20% of people with MG experience a crisis at some point in their lifetime, and it most commonly happens within the first two years of diagnosis. Infections, surgery, certain medications, and physical stress can all trigger it. In-hospital mortality during a myasthenic crisis is around 4.5%, though some estimates range as high as 6% to 10%. Survival rates have improved considerably over the past few decades thanks to better intensive care and faster treatment.
How Severity Is Tracked Day to Day
Beyond the MGFA class, doctors often use a scoring tool called the MG Activities of Daily Living (MG-ADL) scale to track how the disease affects you in practical terms. It scores eight everyday tasks like talking, chewing, breathing, and brushing your hair on a 0 to 3 scale, producing a total score from 0 to 24. Higher scores mean more severe symptoms. This gives a more granular picture than the MGFA class alone, especially for monitoring whether a treatment is working over weeks and months.
Remission and Minimal Disease
The MGFA system also defines what improvement looks like after treatment. Complete stable remission means you’ve had no symptoms or signs of MG for at least a year and haven’t needed any MG medication during that time. Pharmacologic remission is the same symptom-free state, but you’re still taking immunosuppressive treatment to maintain it. A third category, minimal manifestations, applies when you have no functional limitations from MG in daily life but a neurologist can still detect slight weakness on a careful exam.
These categories matter because they set clear benchmarks for treatment goals. Many people with MG achieve pharmacologic remission or minimal manifestations with current therapies, though complete stable remission off all medication is less common.
Why Staging Isn’t Always Linear
One of the most important things to understand about MG stages is that the disease doesn’t march steadily from Class I to Class V. Some people stay in Class I for decades. Others fluctuate between classes depending on stress, illness, medication changes, or even the time of day (MG symptoms are famously worse in the evening). The MGFA classification is a snapshot, not a forecast. Your class at diagnosis doesn’t determine where you’ll end up, and effective treatment can move you to a lower class or into remission at any point.